U.K. Spatial Genomics & Transcriptomics Market Size & Outlook
- Biotechnology
- Genomics & Genetic Engineering
- Spatial Genomics & Transcriptomics Market Outlook
- Genomics & Genetic Engineering
U.K. Spatial Genomics Transcriptomics Market, 2018-2030 (US$M)
Global Market
Related Markets
Ask a question about the spatial genomics & transcriptomics market
UK spatial genomics & transcriptomics market highlights
- The UK spatial genomics & transcriptomics market generated a revenue of USD 26.1 million in 2023 and is expected to reach USD 57.8 million by 2030.
- The UK market is expected to grow at a CAGR of 12% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
Spatial genomics & transcriptomics market data book summary
| Market revenue in 2023 | USD 26.1 million |
| Market revenue in 2030 | USD 57.8 million |
| Growth rate | 12% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Software |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables, Software |
| Key market players worldwide | Natera Inc, 10x Genomics Inc Ordinary Shares - Class A, Dovetail Genomics, Illumina Inc, NanoString Technologies, Seven Bridges, Horizon Discovery, Bio-Techne Corp, S2 Genomics |
Other key industry trends
- In terms of revenue, UK accounted for 8.4% of the global spatial genomics & transcriptomics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK spatial genomics & transcriptomics market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 57.8 million by 2030.
The UK was one of the few European countries to launch a whole genome sequencing program. Genomics England aims at sequencing nearly 100,000 whole genomes from patients suffering from rare diseases & cancer from 11 Genomic Medicine Centres.
The project is undertaken by majority of biotech and pharma players and nearly 10 of them have signed the GENE Consortium in order to access 5,000 sequenced genomes. Some of the companies in this consortium include Roche, AstraZeneca, and GSK.
In October 2018, this project was expanded with an aim to sequence 5 million genomes over the next 5 years. Similarly, the UK is home to several academic institutions that are currently working on development of novel techniques for single cell genomics.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Spatial Genomics & Transcriptomics Market Scope
Spatial Genomics Transcriptomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Natera Inc | View profile | 3,293 | 13011 McCallen Pass, Building A Suite 100, Austin, TX, United States, 78753 | www.natera.com |
| Bio-Techne Corp | View profile | 3,050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | www.bio-techne.com |
| 10x Genomics Inc Ordinary Shares - Class A | View profile | 1,259 | 6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588 | www.10xgenomics.com |
| Horizon Discovery | View profile | 101-250 | Cambridge, Cambridgeshire, United Kingdom, Europe | www.horizondiscovery.com |
| Dovetail Genomics | View profile | 11-50 | Scotts Valley, California, United States, North America | dovetailgenomics.com/ |
| NanoString Technologies | View profile | 251-500 | Seattle, Washington, United States, North America | www.nanostring.com |
| Seven Bridges | View profile | 251-500 | Charlestown, Massachusetts, United States, North America | www.sevenbridges.com/ |
| S2 Genomics | View profile | 11-50 | Livermore, California, United States, North America | s2genomics.com |
U.K. Spatial Genomics & Transcriptomics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Spatial Genomics & Transcriptomics Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 52.87% in 2023.
Horizon Databook has segmented the U.K. spatial genomics & transcriptomics market based on instruments, consumables, software covering the revenue growth of each sub-segment from 2018 to 2030.
The UK was one of the few European countries to launch a whole genome sequencing program. Genomics England aims at sequencing nearly 100,000 whole genomes from patients suffering from rare diseases & cancer from 11 Genomic Medicine Centres.
The project is undertaken by majority of biotech and pharma players and nearly 10 of them have signed the GENE Consortium in order to access 5,000 sequenced genomes. Some of the companies in this consortium include Roche, AstraZeneca, and GSK.
In October 2018, this project was expanded with an aim to sequence 5 million genomes over the next 5 years. Similarly, the UK is home to several academic institutions that are currently working on development of novel techniques for single cell genomics.
- U.K. Spatial Genomics & Transcriptomics Market Product Outlook (Revenue, USD Million , 2018-2030)
- Instruments
- Consumables
- Software
- U.K. Spatial Genomics & Transcriptomics Market Technology Outlook (Revenue, USD Million , 2018-2030)
- Spatial Transcriptomics
- Spatial Genomics
- U.K. Spatial Genomics & Transcriptomics Market End Use Outlook (Revenue, USD Million , 2018-2030)
- Translational Research
- Academic Customers
- Diagnostic Customers
- Pharmaceutical Manufacturer
Reasons to subscribe to Spatial Genomics & Transcriptomics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Spatial Genomics & Transcriptomics Market Outlook databook
- Our clientele includes a mix of Spatial Genomics & Transcriptomics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.K. Spatial Genomics & Transcriptomics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.K. Spatial Genomics & Transcriptomics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
U.K. Spatial Genomics Transcriptomics Market, 2018-2030 (US$M)
UK spatial genomics & transcriptomics market statistics, by product, 2018-2030 (US$M)
